News - MedTech

CEO resigns at troubled plc TruSpine

The CEO of troubled MedTech TruSpine Technologies Plc has resigned amid shareholder unrest. Laure...

Founder completes boardroom coup at BenevolentAI

A boardroom coup at BenevolentAI has been completed after all resolutions proposed at its annual gen...

PlaqueTec raises £6.4m to target coronary artery disease

PlaqueTec, a company aiming to advance precision medicine for coronary artery disease, has raised £...

£247m takeover at Cambridge breast cancer tech firm

A Cambridge-headquartered company developing technology for breast cancer surgery is set to be acqui...

Locate Bio raises £9.2m to develop bone graft substitute

Locate Bio has raised £9.2 million to fund a clinical study of LDGraft, a bone graft substitute for...

Could Owlstone detect TB & HIV from breath?

Owlstone Medical has secured £5.2 million to explore a path by which breath-based testing could be ...

SleepCogni wins funding for child insomnia therapy trial

A company which provides handheld devices that help people self-manage insomnia has received over £...

CN Bio raises £17m to expand organ-on-a-chip solutions

‘Organ-on-a-chip’ firm CN Bio has raised almost £17 million in the first close of its Series B ...

BenevolentAI to close US office, slash more jobs amid boardroom coup

BenevolentAI is to slash more jobs and close its US office amid a boardroom coup led by founder Ken ...

Qureight backed with £7m to tackle lung & heart disease

Qureight has raised almost £7 million in Series A funding to accelerate drug development in lung an...

Founder leads boardroom coup at BenevolentAI

The founder of BenevolentAI is leading a boardroom coup at the high-profile MedTech. Ken Mulvany ...

e-therapeutics plc looks to US, slams risk appetite of UK investors

e-therapeutics plc plans to de-list from the London Stock Exchange’s junior AIM market after slamm...

Subscribe to our newsletter

    This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.